The C/EBP bZIP Domain Can Mediate Lipopolysaccharide Induction of the Proinflammatory Cytokines Interleukin-6 and Monocyte Chemoattractant Protein-1*

C/EBPα, β, and δ are all expressed by bone marrow-derived macrophages. Ectopic expression of any of these transcription factors is sufficient to confer lipopolysaccharide (LPS)-inducible expression of interleukin-6 (IL-6) and monocyte chemoattractant protein-1 (MCP-1) to a B lymphoblast cell line, which normally lacks C/EBP factors and does not display LPS induction of proinflammatory cytokines. Thus, the activities of C/EBPα, β, and δ are redundant in regard to expression of IL-6 and MCP-1. Surprisingly, the bZIP region of C/EBPβ, which lacks any previously described activation domains, can also confer LPS-inducible expression of IL-6 and MCP-1 in stable transfectants. Transient transfections reveal that the bZIP regions of C/EBPβ, C/EBPδ, and, to a lesser extent, C/EBPα can activate the IL-6 promoter and augment its induction by LPS. Furthermore, the transdominant inhibitor, LIP, can activate expression from the IL-6 promoter. The ability of the C/EBPβ bZIP region to activate the IL-6 promoter in transient transfections is completely dependent upon an intact NF-κB-binding site, supporting a model where the bZIP protein primarily functions to augment the activity of NF-κB. Replacement of the leucine zipper of C/EBPβ with that of GCN4 yields a chimeric protein that can dimerize and specifically bind to a C/EBP consensus sequence, but shows a markedly reduced ability to activate IL-6 and MCP-1 expression. These results implicate the leucine zipper domain in some function other than dimerization with known C/EBP family members, and suggest that C/EBP redundancy in regulating cytokine expression may result from their highly related bZIP regions.

[1]  S. Nordeen,et al.  Luciferase reporter gene vectors for analysis of promoters and enhancers. , 1988, BioTechniques.

[2]  C. Hsieh,et al.  Evidence for posttranscriptional regulation of C/EBPalpha and C/EBPbeta isoform expression during the lipopolysaccharide-mediated acute-phase response , 1996, Molecular and cellular biology.

[3]  A. C. Webb,et al.  The human prointerleukin 1 beta gene requires DNA sequences both proximal and distal to the transcription start site for tissue-specific induction , 1993, Molecular and cellular biology.

[4]  F. Gonzalez,et al.  The ability of C/EBP beta but not C/EBP alpha to synergize with an Sp1 protein is specified by the leucine zipper and activation domain , 1997, Molecular and cellular biology.

[5]  M. Yamada,et al.  Complete nucleotide sequence of the gene for human interleukin 1 alpha. , 1986, Nucleic acids research.

[6]  K. Calame,et al.  Ig/EBP-1: a ubiquitously expressed immunoglobulin enhancer binding protein that is similar to C/EBP and heterodimerizes with C/EBP. , 1990, Genes & development.

[7]  K. Calame,et al.  Limited expression of C/EBP family proteins during B lymphocyte development. Negative regulator Ig/EBP predominates early and activator NF-IL-6 is induced later. , 1994, Journal of immunology.

[8]  A. Colangelo,et al.  β-Adrenergic receptor-induced activation of nerve growth factor gene transcription in rat cerebral cortex involves CCAAT/enhancer-binding protein δ , 1998 .

[9]  A. Gingras,et al.  Expression of a translationally regulated, dominant-negative CCAAT/enhancer-binding protein beta isoform and up-regulation of the eukaryotic translation initiation factor 2alpha are correlated with neoplastic transformation of mammary epithelial cells. , 1996, Cancer research.

[10]  P. Johnson,et al.  A family of C/EBP-related proteins capable of forming covalently linked leucine zipper dimers in vitro. , 1991, Genes & development.

[11]  S. Akira,et al.  A nuclear factor for IL‐6 expression (NF‐IL6) is a member of a C/EBP family. , 1990, The EMBO journal.

[12]  E. Ziff,et al.  Three levels of functional interaction determine the activity of CCAAT/enhancer binding protein-alpha on the serum albumin promoter. , 1994, Genes & development.

[13]  A. Baldwin,et al.  Distinct mechanisms for regulation of the interleukin-8 gene involve synergism and cooperativity between C/EBP and NF-kappa B , 1993, Molecular and Cellular Biology.

[14]  C. Zahnow,et al.  Overexpression of C/EBPβ-LIP, a Naturally Occurring, Dominant-Negative Transcription Factor, in Human Breast Cancer , 1997 .

[15]  M. Yano,et al.  A novel cis-acting element controlling the rat CYP2D5 gene and requiring cooperativity between C/EBP beta and an Sp1 factor , 1994, Molecular and cellular biology.

[16]  S. Akira,et al.  A member of the C/EBP family, NF-IL6 beta, forms a heterodimer and transcriptionally synergizes with NF-IL6. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[17]  S. Akira,et al.  Genomic structure of the murine IL-6 gene. High degree conservation of potential regulatory sequences between mouse and human. , 1988, Journal of immunology.

[18]  Valeria Poli,et al.  The Role of C/EBP Isoforms in the Control of Inflammatory and Native Immunity Functions* , 1998, The Journal of Biological Chemistry.

[19]  Arlan Richardson,et al.  Regenerating livers of old rats contain high levels of C/EBPalpha that correlate with altered expression of cell cycle associated proteins , 1998, Nucleic Acids Res..

[20]  S. Snyder,et al.  Macrophage nitric oxide synthase gene: two upstream regions mediate induction by interferon gamma and lipopolysaccharide. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[21]  A. Baldwin,et al.  Functional and physical associations between NF-kappa B and C/EBP family members: a Rel domain-bZIP interaction. , 1993, Molecular and cellular biology.

[22]  B. Rollins,et al.  Cloning and expression of JE, a gene inducible by platelet-derived growth factor and whose product has cytokine-like properties. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[23]  M. Baer,et al.  C/EBP-related protein 2 confers lipopolysaccharide-inducible expression of interleukin 6 and monocyte chemoattractant protein 1 to a lymphoblastic cell line. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[24]  S. Bauer,et al.  Clonal relationship of the lymphoblastic cell line P388 to the macrophage cell line P388D1 as evidenced by immunoglobulin gene rearrangements and expression of cell surface antigens. , 1986, Journal of immunology.

[25]  U. Schibler,et al.  A liver-enriched transcriptional activator protein, LAP, and a transcriptional inhibitory protein, LIP, are translated from the sam mRNA , 1991, Cell.

[26]  Peter F. Johnson,et al.  Redundancy of C/EBPα, -β, and -δ in Supporting the Lipopolysaccharide-Induced Transcription of IL-6 and Monocyte Chemoattractant Protein-1 , 1998, The Journal of Immunology.

[27]  M. Rosenfeld,et al.  Calcium-Regulated Phosphorylation Within the Leucine Zipper of C/EBPβ , 1992, Science.

[28]  C. Cepko,et al.  Construction and applications of a highly transmissible murine retrovirus shuttle vector , 1984, Cell.

[29]  W. Rom,et al.  Regulation of the interleukin-1 beta (IL-1 beta) gene by mycobacterial components and lipopolysaccharide is mediated by two nuclear factor-IL6 motifs , 1993, Molecular and cellular biology.

[30]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[31]  M. F. Shannon,et al.  Synergistic transcriptional activation of the IL-8 gene by NF-kappa B p65 (RelA) and NF-IL-6. , 1994, Journal of immunology.

[32]  S. Akira,et al.  Transcription factors NF-IL6 and NF-kappa B synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[33]  P. Rørth.  Specification of C/EBP function during Drosophila development by the bZIP basic region. , 1994, Science.

[34]  A. Roebroek,et al.  Expression of the dibasic proprotein processing enzyme furin is directed by multiple promoters. , 1994, The Journal of biological chemistry.

[35]  M. Baer,et al.  CRP2 (C/EBP beta) contains a bipartite regulatory domain that controls transcriptional activation, DNA binding and cell specificity. , 1995, The EMBO journal.

[36]  M. Baer,et al.  Autocrine signals control CCAAT/enhancer binding protein beta expression, localization, and activity in macrophages. , 1998, Blood.

[37]  K. Calame,et al.  Ig/EBP (C/EBP gamma) is a transdominant negative inhibitor of C/EBP family transcriptional activators. , 1995, Nucleic acids research.

[38]  S. McKnight,et al.  Isolation of a recombinant copy of the gene encoding C/EBP. , 1988, Genes & development.

[39]  C. Dani,et al.  Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family. , 1985, Nucleic acids research.

[40]  M. Buck,et al.  LAP (NF‐IL‐6), a tissue‐specific transcriptional activator, is an inhibitor of hepatoma cell proliferation. , 1994, The EMBO journal.

[41]  A. Leutz,et al.  Novel mechanism of C/EBP beta (NF-M) transcriptional control: activation through derepression. , 1994, Genes & development.